Estás usando un navegador no soportado
Usar Internet Explorer está desaconsejado por problemas de seguridad. Para ver correctamente esta web, por favor use cualquier navegador moderno: Chrome, Firefox, Edge, Safari u otro de su elección.
En este apartado encontrará una actualización mensual de Trastornos del Movimiento
FILTRAR POR:
Por tema
3323 ARTÍCULOS , VIENDO DEL 886 AL 900
[Legionella pneumophila pneumonia and ataxia]
Monteiro S, Grumete H, Duarte JP, Vieira JR.
Acta Med Port. 2011 Dec;24 Suppl 3:667-70. Epub 2011 Dec 31.
Superficial siderosis of the CNS and otoneurological manifestations
Ramadass T, Narayanan N, Dhanraj M, Chidambarnathan N.
Indian J Otolaryngol Head Neck Surg. 2011 Oct;63(4):380-3. doi: 10.1007/s12070-011-0152-7. Epub 2011 Mar 18.
Implant-supported overdenture in an elderly patient with Huntington's disease
Deniz E, Kokat AM, Noyan A.
Gerodontology. 2011 Jun;28(2):157-60. doi: 10.1111/j.1741-2358.2009.00343.x. Epub 2009 Oct 5.
Giant tumefactive perivascular spaces manifesting as chorea bilaterally
Zacharia TT.
J Neuroimaging. 2011 Apr;21(2):205-7. doi: 10.1111/j.1552-6569.2009.00448.x.
Seeking brain biomarkers for preventive therapy in Huntington disease
Esmaeilzadeh M, Ciarmiello A, Squitieri F.
CNS Neurosci Ther. 2011 Oct;17(5):368-86. doi: 10.1111/j.1755-5949.2010.00157.x. Epub 2010 Jun 11.
Reversible hemichorea associated with extracranial carotid artery stenosis
Pareés I, Pujadas F, Hernández-Vara J, Lorenzo-Bosquet C, Cuberas G, Munuera J, Alvarez-Sabín J.
J Neurol Sci. 2011 Jan 15;300(1-2):185-6. doi: 10.1016/j.jns.2010.08.068.
Neurocognitive signs in prodromal Huntington disease
Stout JC, Paulsen JS, Queller S, Solomon AC, Whitlock KB, Campbell JC, Carlozzi N, Duff K, Beglinger LJ, Langbehn DR, Johnson SA, Biglan KM, Aylward EH.
Neuropsychology. 2011 Jan;25(1):1-14. doi: 10.1037/a0020937.
Giovacchini G, Squitieri F, Esmaeilzadeh M, Milano A, Mansi L, Ciarmiello A.
J Cell Physiol. 2011 Apr;226(4):948-61. doi: 10.1002/jcp.22451.
Johnston TG.
Int Clin Psychopharmacol. 2011 Mar;26(2):114-9. doi: 10.1097/YIC.0b013e3283407775.
Proteasomal dysfunction in aging and Huntington disease
Li XJ, Li S.
Neurobiol Dis. 2011 Jul;43(1):4-8. doi: 10.1016/j.nbd.2010.11.018. Epub 2010 Dec 8.
'I put it on the back burner most days': Living with chronic risk
Etchegary H.
Health (London). 2011 Nov;15(6):633-49. doi: 10.1177/1363459310364162. Epub 2010 Dec 22.
Biomarkers to Enable the Development of Neuroprotective Therapies for Huntington’s Disease
Hersch SM, Rosas HD.
In: Lo DC, Hughes RE, editors. Neurobiology of Huntington's Disease: Applications to Drug Discovery. Boca Raton (FL): CRC Press/Taylor & Francis; 2011. Chapter 11.
RNA- and DNA- Based Therapies for Huntington’s Disease
Meghan S, Neil A.
In: Lo DC, Hughes RE, editors. Neurobiology of Huntington's Disease: Applications to Drug Discovery. Boca Raton (FL): CRC Press/Taylor & Francis; 2011. Chapter 9.
Protein Interactions and Target Discovery in Huntington’s Disease
Miller JP, Hughes RE.
In: Lo DC, Hughes RE, editors. Neurobiology of Huntington's Disease: Applications to Drug Discovery. Boca Raton (FL): CRC Press/Taylor & Francis; 2011. Chapter 3.
Huntington’s Disease: Clinical Experimental Therapeutics
E. Ray D, Ira S.
In: Lo DC, Hughes RE, editors. Neurobiology of Huntington's Disease: Applications to Drug Discovery. Boca Raton (FL): CRC Press/Taylor & Francis; 2011. Chapter 12.
Actualización mensual Regístrese para recibir los avisos de actualización
Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.